Cargando…

CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway

CK2α/CSNK2A1 is involved in cancer progression by phosphorylating various signaling molecules. Considering the role of CSNK2A1 in cancer progression and the phosphorylation of SIRT6 and the role of SIRT6 in chemoresistance through the DNA damage repair pathway, CSNK2A1 and SIRT6 might be involved in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussein, Usama Khamis, Ahmed, Asmaa Gamal, Song, Yiping, Kim, Kyoung Min, Moon, Young Jae, Ahn, Ae-Ri, Park, Ho Sung, Ahn, Su Jin, Park, See-Hyoung, Kim, Jung Ryul, Jang, Kyu Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303481/ https://www.ncbi.nlm.nih.gov/pubmed/34359939 http://dx.doi.org/10.3390/cells10071770

Ejemplares similares

Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma
por: Zhang, Zhongkai, et al.
Publicado: (2020)

Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum
por: Kim, Kyoung Min, et al.
Publicado: (2021)

Co‐operative roles of IL‐4Rα and IL‐13Rα1 in the progression of ovarian carcinomas and the survival of ovarian carcinoma patients
por: Choi, Won Ku, et al.
Publicado: (2023)

Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma
por: Ahn, Sung Woo, et al.
Publicado: (2020)

The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
por: Park, Hye Jeong, et al.
Publicado: (2018)

In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia
por: Alsagaby, Suliman A., et al.
Publicado: (2022)

IL4Rα and IL13Rα1 Are Involved in the Development of Human Gallbladder Cancer
por: Ahn, Sung Woo, et al.
Publicado: (2022)

SIRT6 Is Involved in the Progression of Ovarian Carcinomas via β-Catenin-Mediated Epithelial to Mesenchymal Transition
por: Bae, Jun Sang, et al.
Publicado: (2018)

FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas
por: Kim, Kyoung Min, et al.
Publicado: (2019)

CSNK2 in cancer: pathophysiology and translational applications
por: Strum, Scott W., et al.
Publicado: (2021)

Predictive functional, statistical and structural analysis of CSNK2A1 and CSNK2B variants linked to neurodevelopmental diseases
por: Unni, Prasida, et al.
Publicado: (2022)

In Skeletal Muscle Fibers, Protein Kinase Subunit CSNK2A1/CK2α Is Required for Proper Muscle Homeostasis and Structure and Function of Neuromuscular Junctions
por: Merholz, Mira, et al.
Publicado: (2022)

Loss of Protein Kinase Csnk2b/CK2β at Neuromuscular Junctions Affects Morphology and Dynamics of Aggregated Nicotinic Acetylcholine Receptors, Neuromuscular Transmission, and Synaptic Gene Expression
por: Eiber, Nane, et al.
Publicado: (2019)

SCRIB Is Involved in the Progression of Ovarian Carcinomas in Association with the Factors Linked to Epithelial-to-Mesenchymal Transition and Predicts Shorter Survival of Diagnosed Patients
por: Hussein, Usama Khamis, et al.
Publicado: (2021)

FAM83H and Nectin1 expression are related with survival and relapse of bladder urothelial carcinoma patients
por: Ahn, Ae-Ri, et al.
Publicado: (2021)

Targeting Csnk1a1 in leukemia
por: Stegmaier, Kimberly
Publicado: (2014)

CK2 Is the Regulator of SIRT1 Substrate-Binding Affinity, Deacetylase Activity and Cellular Response to DNA-Damage
por: Kang, Hyeog, et al.
Publicado: (2009)

FAM83H and SCRIB stabilize β-catenin and stimulate progression of gastric carcinoma
por: Hussein, Usama Khamis, et al.
Publicado: (2020)

Germline de novo variants in CSNK2B in Chinese patients with epilepsy
por: Li, Jinliang, et al.
Publicado: (2019)

The Expression Patterns of FAM83H and PANX2 Are Associated With Shorter Survival of Clear Cell Renal Cell Carcinoma Patients
por: Kim, Kyoung Min, et al.
Publicado: (2019)

Mustard Seed (Brassica nigra) Extract Exhibits Antiproliferative Effect against Human Lung Cancer Cells through Differential Regulation of Apoptosis, Cell Cycle, Migration, and Invasion
por: Ahmed, Asmaa Gamal, et al.
Publicado: (2020)

Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway
por: Park, See-Hyoung, et al.
Publicado: (2018)

CSNK2A1‐mediated phosphorylation of HMGA2 modulates cisplatin resistance in cervical cancer
por: Shi, Zhan, et al.
Publicado: (2021)

CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling
por: Yu, Shijun, et al.
Publicado: (2021)

Two different presentations of de novo variants of CSNK2B: two case reports
por: Wilke, Matheus V. M. B, et al.
Publicado: (2022)

De Novo CSNK2B Mutations in Five Cases of Poirier–Bienvenu Neurodevelopmental Syndrome
por: Yang, Qi, et al.
Publicado: (2022)

Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses
por: Yang, Xuan, et al.
Publicado: (2022)

Long noncoding RNA HIKER regulates erythropoiesis in Monge’s disease via CSNK2B
por: Azad, Priti, et al.
Publicado: (2023)

The Multiple Personalities of the Regulatory Subunit of Protein Kinase CK2: CK2 Dependent and CK2 Independent Roles Reveal a Secret Identity for CK2β
por: Bibby, Ashley C., et al.
Publicado: (2005)

Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis
por: Park, See-Hyoung, et al.
Publicado: (2020)

Prognostic value and immunological role of CSNK1D in human cancers
por: Wang, Jianguo, et al.
Publicado: (2023)

Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
por: Wang(a), Jie, et al.
Publicado: (2022)

Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2
por: Yang, Xuan, et al.
Publicado: (2022)

CK2: channel controller
por: Williams, Ruth
Publicado: (2008)

Mining CK2 in Cancer
por: Ortega, Charina E., et al.
Publicado: (2014)

CK2 and the Hallmarks of Cancer
por: Firnau, May-Britt, et al.
Publicado: (2022)

Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes
por: Yang, Cui-Ping, et al.
Publicado: (2018)

Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer
por: Samec, Timothy, et al.
Publicado: (2022)

Malaria Protein Kinase CK2 (PfCK2) Shows Novel Mechanisms of Regulation
por: Graciotti, Michele, et al.
Publicado: (2014)

CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer
por: Sauta, Elisabetta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j22sk1vl0fdqqq6vtgrr5a6kev